January 15, 2026 · PRODUCTS
CAS-R-2 Frameless Stereotactic System
China's earliest NMPA-approved neurosurgical robot featuring frameless stereotactic technology with 0.8mm positioning accuracy.
›2 articles
China's earliest NMPA-approved neurosurgical robot featuring frameless stereotactic technology with 0.8mm positioning accuracy.
›Neurosurgical robot with 0.5mm positioning accuracy supporting nearly 100 procedures across 12 categories including DBS and hematoma aspiration; per Frost & Sullivan's 2023 report, Remebot holds 52.6% share of China's neurosurgical robot market.
›